<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> plasma levels were measured by high-performance liquid chromatography in 52 patients with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>Elevated <z:chebi fb="0" ids="17230">homocysteine</z:chebi> concentrations (&gt;or= 15 micromol/l) were found in 16/52 (30.8%) APS patients </plain></SENT>
<SENT sid="2" pm="."><plain>Elevated <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels were found to be associated with an increased risk for a major thromboembolic event (50 versus 16.7%, P = 0.014) </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">Hyperhomocysteinemia</z:e> is a common finding in APS patients, and may contribute to severity of thrombotic tendency observed in this syndrome </plain></SENT>
</text></document>